Similar articles

• [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].

  Couroucé AM. Couroucé AM. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):335-8. doi: 10.1016/s1140-4639(05)80039-5. Rev Fr Transfus Hemobiol. 1990. PMID: 2177594 Review. French. No abstract available.
• Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.

  Contreras M, Barbara JA, Anderson CC, Ranasinghe E, Moore C, Brennan MT, Howell DR, Aloysius S, Yardumian A. Contreras M, et al. Lancet. 1991 Mar 30;337(8744):753-7. doi: 10.1016/0140-6736(91)91370-a. Lancet. 1991. PMID: 1672391 Clinical Trial.
• [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].

  Janot C. Janot C. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):347-50. doi: 10.1016/s1140-4639(05)80042-5. Rev Fr Transfus Hemobiol. 1990. PMID: 2177596 French. No abstract available.
• [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].

  Jullien AM, Courouce AM, Maniez M, Brevière D, Menault M, Finetti P, Girard M. Jullien AM, et al. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):355-8. doi: 10.1016/s1140-4639(05)80044-9. Rev Fr Transfus Hemobiol. 1990. PMID: 2177598 French. No abstract available.
• [Anti-HVC antibodies and raw-material plasma: reflections and strategy].

  Avenard G, Maquin A, Schoeffter C, Mangin C. Avenard G, et al. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):351-4. doi: 10.1016/s1140-4639(05)80043-7. Rev Fr Transfus Hemobiol. 1990. PMID: 2177597 Review. French. No abstract available.